FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma

BACKGROUND: Despite the scarcity of data based on randomized trials, FOLFIRINOX is widely used in the management of borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). We investigated the clinical outcomes of neoadjuvant FOLFIRINOX in patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Yoo, Changhoon, Hwang, Inhwan, Song, Tae Jun, Lee, Sang Soo, Jeong, Jae Ho, Park, Do Hyun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Byun, Jae Ho, Park, Jin-hong, Hwang, Dae Wook, Song, Ki Byung, Lee, Jae Hoon, Lee, Woohyung, Chang, Heung-Moon, Kim, Kyu-pyo, Kim, Song Cheol, Ryoo, Baek-Yeol
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498966/
https://ncbi.nlm.nih.gov/pubmed/32983266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920953294
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados